[VALUE OF THE -2PROPSA INDEX AND THE PROSTATE HEALTH INDEX IN PATIENTS WITH PROSTATE CANCER: REVIEW OF LITERATURE AND...

Area of Science:

• Biochemistry
• Oncology
• Urology

Context:

• Prostate cancer (PCa) diagnosis relies on various markers, but improved specificity and early detection remain critical.
• Existing diagnostic methods can lead to unnecessary invasive procedures like biopsies.

Purpose:

• To analyze fundamental studies on -2proPSA and prostate health index (PHI).
• To determine the clinical utility of these markers in prostate cancer management.
• To evaluate their role in improving PCa detection and reducing unnecessary biopsies.

Summary:

• -2proPSA and prostate health index (PHI) offer enhanced detection of prostate cancer.
• These markers increase diagnostic specificity, aiding in the reduction of unnecessary prostate biopsies.
• They also assist in identifying aggressive PCa forms and monitoring disease progression.

Impact:

• The findings support the integration of -2proPSA and PHI testing into routine urological practice.
• This can lead to more accurate and efficient prostate cancer diagnosis and patient management.
• Early identification of aggressive disease and reduced biopsy rates are key benefits.